Skip to main content
Clinical Trials/NCT02564731
NCT02564731UnknownNot Applicable

Prognosis of Bronchiectasis in Children--A Multicenter Prospective Cohort Study

Baoping XU1 site in 1 country300 target enrollmentStarted: June 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
300
Locations
1
Primary Endpoint
Change from baseline in lung function on the spirometry

Study Overview

Brief Summary

This prospective cohort study is designed to observe of the effect of intervention therapy on the long-term prognosis of children with bronchiectasis. The main purpose of the study was to evaluate the degree of deterioration of lung function, to observe and compare the quality of life, the time of pulmonary exacerbation, and the changes of lung image.

Detailed Description

All enrolled patients are followed up for half a year, 1 years, 2 years, 3 years, 4 years, 5 years, while observation of pulmonary function, symptoms, signs, quality of life, the times of acute pulmonary exacerbation, and the changes of lung image are performed.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
— to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • A included patient must be coincident at least one point of the four items of high-resolution computed tomography (HRCT) manifestations.
  • Internal bronchial diameter greater than the accompanying pulmonary artery.
  • lack of bronchial tapering
  • bronchi visible in the peripheral 1cm of lung
  • bronchial diameter greater than adjacent segmental bronchi

Exclusion Criteria

  • Subject will be excluded if she or he has one of the following
  • It is unable or doesn't agree to accept the follow-up process
  • undergoing trial for other medications or instruments.

Outcomes

Primary Outcomes

Change from baseline in lung function on the spirometry

Time Frame: 5 years

forced expiratory volume at one second (FEV1) in Liter

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Baoping XU
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Baoping XU

Chief of Respiratory Department

Beijing Children's Hospital

Study Sites (1)

Loading locations...

Similar Trials

Prognosis of Bronchiectasis in Children--A... | Clinical Trial